Biomaterials in ophthalmic plastic and reconstructive surgery

Current Opinion in Ophthalmology

Volumn 9, Issue 5, 1998, Pages 66-74

  Karesh, James W ^a  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOY; BIOMATERIAL; CYANOACRYLATE DERIVATIVE; HEAVY METAL; HYDROXYAPATITE; METAL; MINERAL; PLASTIC; POLYESTER; POLYETHYLENE; POLYMER; SILICON; TECHNETIUM;

BONE SCINTISCANNING; ENUCLEATION; EVISCERATION; EYE SURGERY; HUMAN; IMPLANT; LACRIMAL APPARATUS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT RECONSTRUCTION; PLASTIC SURGERY; POLITEF IMPLANT; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOCOMPATIBLE MATERIALS; EYE DISEASES; HUMANS; OPHTHALMOLOGIC SURGICAL PROCEDURES; ORBITAL DISEASES; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RECONSTRUCTIVE SURGICAL PROCEDURES;

EID: 0031770394     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199810000-00013     Document Type: Review

References (122)

1. Jordan DR, Anderson RL: The universal implant for evisceration surgery. Ophthal Plast Reconstr Surg 1997, 13:1-7.
2. Shields JA, Shields CL, De Potter P: Hydroxyapatite orbital implant after enucleation: experience with 200 cases. Mayo Clin Proc 1993, 68:1191-1195.
3. Karesh JW, Horswell BB: Correction of late enophthalmos with polyethylene implant. J Craniomaxillofac Trauma 1996, 2:18-23.
4. Yang JG, Khwarg SI, Wee WR, Kim DM, Lee JH: Hydroxyapatite implantation with scleral quadrisection after evisceration. Ophthal Surg Lasers 1997, 28:915-919. The authors point out the need for opening up the posterior sclera if hydroxyapatite implants are utilized for eviscerations. This allows for more vigorous fibrovascular ingrowth and may reduce the incidence of implant exposure.
5. Jordan DR, Parisi J: The scleral filet technique for secondary orbital implantation surgery. Can J Ophthalmol 1996, 31:356-361.
6. Massry GG, Holds JB: Coralline hydroxyapatite spheres as secondary orbital implants in anophthalmos. Ophthalmology 1995, 102:161-166.
7. Hornblass A, Biesman BS, Eviatar JA: Current techniques of enucleation: a survey of 5,439 intraorbital implants and a review of the literature. Ophthal Plast Reconstr Surg 1995, 11:77-86; discussion 87-88.
8. Shields CL, Shields JA, De Potter P, Singh AD: Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc 1993, 91:177-189; discussion 189-195.
9. Oestreicher JH, Liu E, Berkowitz M: Complications of hydroxyapatite orbital implants: a review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping [see comments]. Ophthalmology 1997, 104:324-329. This is a very good retrospective review of one surgeon's experience with hydroxyapatite enucleation implants. The low rate of exposure is encouraging, and the use of polyglycolic acid mesh is an interesting innovation for avoiding the use of cadaver sclera and the various problems associated with donated tissue
10. Naugle TC Jr, Fry CL, Sabatier RE, Elliott LF: High leg incision fascia lata harvesting. Ophthalmology 1997, 104:1480-1488.
11. Lee SY, Kim HY, Kim SJ, Kang SJ: Human dura mater as a wrapping material for hydroxyapatite implantation in the anophthalmic socket. Ophthalmic Surg Lasers 1997, 28:428-431.
12. Jordan DR, Ells A, Brownstein S, Munro SM, Grahovac SZ, Raymond F, et al.: Vicryl-mesh wrap for the implantation of hydroxyapatite orbital implants: an animal model. Can J Ophthalmol 1995, 30:241-246.
13. Jordan DR, Allen LH, Ells A, et al.: The use of Vicryl mesh (polyglactin 910) for implantation of hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 1995, 11:95-99.
14. Rubin PA, Popham JK, Bilyk JR, Shore JW: Comparison of fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants. Ophthal Plast Reconstr Surg 1994, 10:96-103.
15. Sekundo W, Seifert P: Hydroxyapatite orbital implant: a light-and electron-microscopic and immunohistochemical study. Ophthalmology 1998, 105:539-543.
16. Sires BS, Holds JB, Kincaid MC, Reddi AH: Osteogenin-enhanced bone-specific differentiation in hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 1997, 13:244-251. This is a good initial attempt to examine factors for enhancing fibrovascular ingrowth within hydroxyapatite implants.
17. Nicaeus TE, Tolentino MJ, Adamis AP, Rubin PA: Sucralfate and basic fibroblast growth factor promote endothelial cell proliferation around porous alloplastic implants in vitro. Ophthal Plast Reconstr Surg 1996, 12:235-239.
18. Pacheco EM, Civelek AC, Natarajan TK, D'Anna SA, Iliff NT, Green WR: Clinicopathological correlation of technetium bone scan in vascularization of hydroxyapatite implants: a primate model. Arch Ophthalmol 1997, 115:1173-1177. This experimental model of hydroxyapatite orbital implants demonstrates the usefulness of a technetium bone scan for demonstrating fibrovascular ingrowth.
19. Civelek AC, Pacheco EM, Natarajan TK, Wagner HN Jr, Iliff NT: Quantitative measurement of vascularization and vascular ingrowth rate of coralline hydroxyapatite ocular implant by Tc-99m MDP bone imaging. Clin Nucl Med 1995, 20:779-787.
20. Jamell GA, Hollsten DA, Hawes MJ, et al.: Magnetic resonance imaging versus bone scan for assessment of vascularization of the hydroxyapatite orbital implant. Ophthal Plast Reconstr Surg 1996, 12:127-130.
21. Flanders AE, De Potter P, Rao VM, Tom BM, Shields CL, Shields JA: MRI of orbital hydroxyapatite implants. Neuroradiology 1996, 38:273-277.
22. Spirnak JP, Nieves N, Hollsten DA, White WC, Betz TA: Gadolinium-enhanced magnetic resonance imaging assessment of hydroxyapatite orbital implants. Am J Ophthalmol 1995, 119:431-440.
23. Sires BS, Holds JB, Archer CR, Kincaid MC, Hageman GS: Histological and radiological analyses of hydroxyapatite orbital implants in rabbits. Ophthal Plast Reconstr Surg 1995, 11:273-277.
24. McNab A: Hydroxyapatite orbital implants: experience with 100 cases. Aust N Z J Ophthalmol 1995, 23:117-123.
25. Remulla HD, Rubin PA, Shore JW, et al.: Complications of porous spherical orbital implants. Ophthalmology 1995, 102:586-593.
26. Kim YD, Goldberg RA, Shorr N, Steinsapir KD: Management of exposed hydroxyapatite orbital implants [see comments]. Ophthalmology 1994, 101:1709-1715.
27. Oestreicher JH: Treatment of exposed coral implant after failed scleral patch graft. Ophthal Plast Reconstr Surg 1994, 10:110-113.
28. el-Shahed FS, Sherif MM, Ali AT: Management of tissue breakdown and exposure associated with orbital hydroxyapatite implants. Ophthal Plast Reconstr Surg 1995, 11:91-94.
29. Karcioglu ZA: Actinomyces infection in porous polyethylene orbital implant. Graefes Arch Clin Exp Ophthalmol 1997, 235:448-451.
30. Kristinsson JK, Sigurdsson H, Sigfusson A, Gudmundsson S, Agnarsson BA: Detection of orbital implant infection with technetium 99m-labeled leukocytes. Ophthal Plast Reconstr Surg 1997, 13:256-258.
31. Glasgow BJ, Weinberg DA, Shorr N, Goldberg RA: Draining cutaneous fistula associated with infection of hydroxyapatite orbital implant. Ophthal Plast Reconstr Surg 1996, 12:131-135.
32. Jordan DR, Brownstein S, Jolly SS: Abscessed hydroxyapatite orbital implants: a report of two cases [see comments]. Ophthalmology 1996, 103:1784-1787.
33. Wachler BS, Holds JB: Difficulties with hydroxyapatite orbital implants in two patients with dysfunctional levator/superior reclus muscle complex. Ophthal Plast Reconstr Surg 1997, 13:252-255.
34. Wortham E, Choi RY, Young SR: Botulinum A toxin treatment of a deviated orbital implant. J Pediatr Ophthalmol Strabismus 1995, 32:191-193.
35. Edelstein C, Shields CL, De Potter P, Shields JA: Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology 1997, 104:1616-1621. This is an outstanding examination of a significant series of implants in which motility pegs have been placed, and of the complications associated with this technique. The usefulness of sleeved pegs is stressed.
36. Hoick DE, DeBacker CM, Dutton JJ: Deviated hydroxyapatite orbital implant syndrome. Am J Ophthalmol 1997, 124:123-125.
37. Rubin PA, Bilyk JR, Shore JW: Orbital reconstruction using porous polyethylene sheets. Ophthalmology 1994, 101:1697-1708.
38. Haug RH, Kimberly D, Bradrick JP: A comparison of microscrew and suture fixation for porous high-density polyethylene orbital floor implants. J Oral Maxillofac Surg 1993, 51:1217-1220.
39. Mauriello JA Jr, Antonacci R, Mostafavi R: Hinged silicone covered metallic implant for repair of large fractures of the internal orbital skeleton. Ophthal Plast Reconstr Surg 1995, 11:59-65.
40. Morrison AD, Sanderson RC, Moos KF: The use of silastic as an orbital implant for reconstruction of orbital wall defects: review of 311 cases treated over 20 years. J Oral Maxillofac Surg 1995, 53:412-417.
41. Laxenaire A, Levy J, Blanchard P, Lerondeau JC, Tesnier F, Scheffer P: [Complications of silastic implants used in orbital repair]. Rev Stomatol Chir Maxillofac 1997, 98(suppl 1):96-99.
42. Gregory GF: Silicone-associated tissue reaction: a dilemma for oral and maxillofacial surgeons. Br J Oral Maxillofac Surg 1995, 33:180-184.
43. Rubin PA, Shore JW, Yaremchuk MJ: Complex orbital fracture repair using rigid fixation of the internal orbital skeleton. Ophthalmology 1992, 99:553-559.
44. Sugar AW, Kuriakose M, Walshaw ND. Titanium mesh in orbital wall reconstruction. Int J Oral Maxillofac Surg 1992, 21:140-144.
45. Sengezer M. Sadove RC: Reconstruction of midface bone defects with vitallium micromesh. J Craniofac Surg 1992, 3:125-133.
46. Hanson LJ, Donovan MG, Hellstem JW, Dickerson NC: Experimental evaluation of expanded polytetrafluoroethylene for reconstruction of orbital floor defects. J Oral Maxillofac Surg 1994, 52:1050-1055; discussion 1056-1057.
47. Mercier J, Plot B, Gueguen P, et al.: [The coral orbital floor: its value in traumatology: the results of a multicenter study of 83 cases]. Rev Stomatol Chir Maxillofac 1996, 97:324-331.
48. Ono I, Gunji H, Suda K, Kaneko F. Yago K: Orbital reconstruction with hydroxyapatite ceramic implants. Scand J Plast Reconstr Surg Hand Surg 1994, 28:193-198.
49. Rosen CE: Late migration of an orbital implant causing orbital hemorrhage with sudden proptosis and diplopia. Ophthal Plast Reconstr Surg 1996, 12:260-262; discussion 263.
50. Paoli JR, Dodart L, Boutault F, Lauwers F, Fabie M: [Reconstruction of the orbit floor using a resorbable polydioxanone (PDS degree) cup: analysis of a series of 71 cases]. Rev Stomatol Chir Maxillofac 1995, 96:113-116.
51. Merten HA, Luhr HG: [Resorbable synthetics (PDS foils) for bridging extensive orbital wall defects in an animal experiment comparison]. Fortschr Kiefer Gesichtschir 1994, 39:186-190.
52. Iizuka T, Mikkonen P, Paukku P, Lindqvist C: Reconstruction of orbital floor with polydioxanone plate. Int J Oral Maxillofac Surg 1991, 20:83-87.
53. Mauriello JA Jr, Margrave S, Yee S, Mostafavi R, Kapila R: Infection after insertion of alloplastic orbital floor implants. Am J Ophthalmol 1994, 117:246-252.
54. Jordan DR: Microplate fixation of prefabricated subperiosteal orbital floor implants. Ophthalmic Surg 1995, 26:78-79.
55. Yeatts RP, Harvey J, Bartley GB, Nerney JJ: Ocular injury secondary to periorbital use of stainless-steel wire and suture. Arch Ophthalmol 1994, 112:213-216.
56. Ahn DK, Sims CD, Randolph MA, et al.: Craniofacial skeletal fixatíon using biodegradable plates and cyanoacrylate glue. Plast Reconstr Surg 1997, 99:1508-1515; discussion 1516-1517. Biodegradable screw and plates for use in fracture repair are at the cutting edge of surgical techniques. This study demonstrates that cyanoacrylate glue and resorbable plates can be successfully utilized for rigid fixation of bone fragments in an animal model.
57. Kellman RM, Huckins SC, King J, Humphrey D, Marentette L, Osborn DC: Bioresorbable screws for facial bone reconstruction: a pilot study in rabbits. Laryngoscope 1994, 104:556-561.
58. Gosain AK, Song L, Corrao MA, Pintar FA: Biomechanical evaluation of titanium, biodegradable plate and screw, and cyanoacrylate glue fixation systems in craniofacial surgery. Plast Reconstr Surg 1998, 101:582-591. This experimental model shows that bioabsorbable plates and screws have mechanical characteristics similar to and in some cases greater than currently available metal-based screws and plates.
59. Eppley BL, Sadove AM, Havlik RJ: Resorbable plate fixation in pediatric craniofacial surgery. Plast Reconstr Surg 1997, 100:1-7; discussion 8-13. The usefulness of bioabsorbable screws and plates in the pediatric age group is confirmed by this study. These devices provide an important alternative to metal-based implants if there are concerns about normal bony structural growth.
60. Weisberger EC, Eppley BL. Resorbable fixation plates in head and neck surgery. Laryngoscope. 1997, 107:716-719. This is a extensive examination of bioabsorbable plates in a large series of patients undergoing craniofacial reconstruction, fracture repair, and craniotomy repair.
61. Hemprich A, Breier T: Secondary correction of traumatogenic enophthalmos with auto-and alloplastic implants. Rev Stomatol Chir Maxillofac 1993, 94:37-39.
62. Hoffmann J, Cornelius CP, Groten M, Probster L, Pfannenberg C, Schwenzer N: Orbital reconstruction with individually copy-milled ceramic implants. Plast Reconstr Surg 1998, 101:604-612.
63. Burstein FD, Cohen SR, Hudgins R, Boydston W: The use of porous granular hydroxyapatite in secondary orbitocranial reconstruction. Plast Reconstr Surg 1997, 100:869-874. This study demonstrates the usefulness of hydroxyapatite granules in reforming bony contour defects. This material appears to be an acceptable alternative to other currently available techniques.
64. Couldwell WT, Chen TC, Weiss MH, Fukushima T, Dougherty W: Cranioplasty with the Medpor porous polyethylene flexblock implant: technical note. J Neurosurg 1994, 81:483-486.
65. Shah S, Rhatigan M, Sampath R, et al.: Use of Proplast II as a subperiosteal implant for the correction of anophthalmic enophthalmos. Br J Ophthalmol 1995, 79:830-833.
66. Nasr AM, Jabak MH, Batainah Y: Orbital volume augmentation with subperiosteal room-temperature-vulcanized silicone implants: a clinical and histopathologic study. Ophthal Plast Reconstr Surg 1994, 10:11-21; discussion 22-23.
67. Hes J, de Man K: Use of blocks of hydroxylapatite for secondary reconstruction of the orbital floor. Int J Oral Maxillofac Surg 1990, 19:275-278.
68. Janecka IP: Correction of ocular dystopia. Plast Reconstr Surg 1996, 97:892-899.
69. Kennedy RE: The effect of early enucleation on the orbit in animals and humans. Adv Ophthalmic Plast Reconstr Surg 1992, 9:1-39.
70. Tucker SM, Sapp N, Collin R: Orbital expansion of the congenitally anophthalmic socket. Br J Ophthalmol 1995, 79:667-671.
71. Cepela MA, Nunery WR, Martin RT: Stimulation of orbital growth by the use of expandable implants in the anophthalmic cat orbit. Ophthal Plast Reconstr Surg 1992, 8:157-167; discussion 168-169.
72. Heinz GW, Nunery WR, Cepela MA: The effect of maturation on the ability to stimulate orbital growth using tissue expanders in the anophthalmic cat orbit. Ophthal Plast Reconstr Surg 1997, 13:115-128. The management of the anophthalmic socket in the pediatric age group is difficult and often associated with a failure to achieve normal volumetric measurements. This study demonstrates that indwelling inflatable silicone implants may be the solution to managing this problem.
73. Tse DT, McCafferty LR: Controlled tissue expansion in periocular reconstructive surgery. Ophthalmology 1993, 100:260-268.
74. Rohrich RJ, Beran SJ: Evolving fixation methods in endoscopically assisted forehead rejuvenation: controversies and rationale. Plast Reconstr Surg 1997, 100:1575-1582; discussion 1583-1584. This is an extensive examination of various interosseous metallic and nonmetallic implants for use in endoscopic forehead surgery.
75. Mauriello JA Jr, Caputo AR: Treatment of congenital forms of telecanthus with custom-designed titanium medial canthal tendon screws. Ophthal Plast Reconstr Surg 1994, 10:195-199.
76. Kosmidou L, Toljanic JA, Moran WJ, Panje WR: The use of percutaneous implants for the prosthetic rehabilitation of orbital defects in irradiated cancer patients: a report of clinical outcomes and complications. Int J Oral Maxillofac Implants 1998, 13:121-126. Interosseous implants for retention of an external prosthesis are an important adjunct to the rehabilitation of patients following extensive surgery and radiation for head-and-neck cancers. This is very good examination of this subject in 24 patients and demonstrates a 90% success rate in achieving osseointegration of these implants.
77. Tolman DE, Taylor PF: Bone-anchored craniofacial prosthesis study. Int J Oral Maxillofac Implants 1996, 11:159-168.
78. Tolman DE, Taylor PF: Bone-anchored craniofacial prosthesis study: irradiated patients. Int J Oral Maxillofac Implants 1996, 11:612-619.
79. Rubenstein JE: Attachments used for implant-supported facial prostheses: a survey of United States, Canadian, and Swedish centers. J Prosthet Dent 1995, 73:262-266.
80. Wolfaardt JF, Wilkes GH, Parel SM, Tjellstrom A: Craniofacial osseointegration: the Canadian experience. Int J Oral Maxillofac Implants 1993, 8:197-204.
81. Klein M, Menneking H, Neumann K, Hell B, Bier J: Computed tomographic study of bone availability for facial prosthesis-bearing endosteal implants. Int J Oral Maxillofac Surg 1997, 26:268-271. This study shows the importance of computed tomography for evaluating bone thickness prior to placement of interosseous implants.
82. Khan Z, Bowden M, Beam D: Modified bar superstructure for an implant-retained orbital prosthesis. J Prosthodont 1994, 3:65-67.
83. Lerner TH, Huryn JM: Orbital prosthesis with a magnetically retained ocular component supported by osseointegrated implants. J Prosthet Dent 1993, 69:378-380.
84. Gary JJ, Donovan M: Retention designs for bone-anchored facial prostheses. J Prosthet Dent 1993, 70:329-332.
85. Niimi A, Fujimoto T, Nosaka Y, Ueda M: A Japanese multicenter study of osseointegrated implants placed in irradiated tissues: a preliminary report. Int J Oral Maxillofac Implants 1997, 12:259-264. This large study show the feasibility of using interosseous implants in irradiated bone and the usefulness of adjunctive hyperbaric oxygen treatment for enhancing osseointegration.
86. Gitto CA, Plata WG, Schaaf NG: Evaluation of the peri-implant epithelial tissue of percutaneous implant abutments supporting maxillofacial prostheses. Int J Oral Maxillofac Implants 1994, 9:197-206.
87. Lundgren S, Moy PK, Beumer Jd, Lewis S: Surgical considerations for endosseous implants in the craniofacial region: a 3-year report. Int J Oral Maxillofac Surg 1993, 22:272-277.
88. Jacobsson M, Tjellstrom A, Fine L, Andersson H: A retrospective study of osseointegrated skin-penetrating titanium fixtures used for retaining facial prostheses. Int J Oral Maxillofac Implants 1992, 7:523-528.
89. Janssen AG, Mansour K, Bos JJ: Obstructed nasolacrimal duct system in epiphora: long-term results of dacryocystoplasty by means of balloon dilation. Radiology 1997, 205:791-796. This is one of the few studies to examine the long-term results of balloon dacryoplasty in the management of nasolacrimal duct obstructions. This procedure appears to have at least a 70% rate of success in alleviating epiphora. The authors suggest that this should be the first approach for partial nasolacrimal duct obstructions.
90. Berkefeld J, Kirchner J, Muller HM, Fries U, Kollath J: Balloon dacryocystoplasty: indications and contraindications. Radiology 1997, 205:785-790. This is a short-term study of balloon dacryoplasty. The authors achieved a 92% rate of successful alleviation of epiphora with partial nasolacrimal duct obstructions but only a 54% rate of success in complete obstructions. They suggest that the use of this technique be reserved for those individuals with partial obstructions.
91. Song HY, Lee CO, Park S, et al.: Lacrimal canalicular obstructions: safety and effectiveness of balloon dilation. J Vasc Interv Radiol 1996, 7:929-934.
92. Becker BB, Berry FD, Koller H: Balloon catheter dilatation for treatment of congenital nasolacrimal duct obstruction [see comments]. Am J Ophthalmol 1996, 121:304-309.
93. Liermann D, Berkefeld J, Fries U, Schalnus RW, Gumpel H: Balloon dacryocystoplasty: an alternative treatment for obstructed tear ducts. Ophthalmologica 1996, 210:319-324.
94. Ilgit ET, Yuksel D, Unal M, Akpek S, Isik S, Hasanreisoglu B: Transluminal balloon dilatation of the lacrimal drainage system for the treatment of epiphora. AJR Am J Roentgenol 1995, 165:1517-1524.
95. Pulido-Duque JM, Reyes R, Carreira JM, et al.: Treatment of complete and partial obstruction of the nasolacrimal system with polyurethane stents: initial experience. Cardiovasc Intervent Radiol 1998, 21:41-44.
96. Song HY, Lee CO, Park S, et al.: Lacrimal canaliculus obstruction: nonsurgical treatment with a newly designed polyurethane stent. Radiology 1996, 199:280-282.
97. Liao CL, Kao SC, Lin PR, Wu KC, Hou PK: Silicone intubation with tissue glue anastomosis in the treatment of congenital nasolacrimal duct obstruction. Ophthalmic Surg Lasers 1996, 27:197-199.
98. Mauriello JA Jr, Abdelsalam A: Use of a modified monocanalicular silicone stent in 33 eyelids. Ophthalmic Surg Lasers 1996, 27:929-934.
99. Zilelioglu G, Gunduz K: Conjunctivodacryocystorhinostomy with Jones tube. A 10-year study. Doc Ophthalmol 1996, 92:97-105.
100. Rose GE, Welham RA: Jones' lacrimal canalicular bypass tubes: twenty-five years' experience. Eye 1991, 5:13-19.
101. Soparkar CN, Patrinely JR, Hunts J, Linberg JV, Kersten RC, Anderson R: The perils of permanent punctal plugs. Am J Ophthalmol 1997, 123:120-121. The authors point out the often-overlooked complications of punctal plug placement, especially issues of plug migration associated with chronic epiphora and dacryocystitis. The use of intracanalicular plugs should be discouraged, as they appear to have a higher rate of migration requiring surgical intervention.
102. Carter SR, Meecham WJ, Seiff SR: Silicone frontalis slings for the correction of blepharoptosis: indications and efficacy [see comments]. Ophthalmology 1996, 103:623-630.
103. Goldberger S, Conn H, Lemor M: Double rhomboid silicone rod frontalis suspension. Ophthal Plast Reconstr Surg 1991, 7:48-53.
104. Lam DS, Gandhi SR, Ng JS, Chen IN, Kwok PS, Chan GH: Early correction of severe unilateral infant ptosis with the Mersilene mesh sling. Eye 1997, 11:806-809. Mersilene mesh appears to be an excellent method for surgically correcting congenital ptosis at an early age in patients with poor levator function.
105. Gabrieli CB, Recupero SM, Contestabile MT, Pacella E, Abdolrahimzadeh S: Fox's modified technique using the Mersilene mesh sling in the management of blepharoptosis. Ophthalmic Surg Lasers 1996, 27:924-928.
106. Can I, Can B, Yarangumeli A, Inan Y, Kural G: Rosis surgery using Mersilene mesh suspensory material. Eur J Ophthalmol 1996, 6:150-154.
107. Manners RM, Tyers AG, Morris PJ: The use of Prolene as a temporary suspensory material for brow suspension in young children. Eye 1994, 8:346-348.
108. Wang HZ, Chang CH, Su MY, Quo SL: Use of Gore-Tex sling in brow suspension procedure. Kao Hsiung I Hsueh Ko Hsueh Isa Chih 1994, 10:131-137.
109. Sleinkogler FJ, Kuchar A, Huber E, Arocker-Mettinger E: Gore-Tex soft-tissue patch frontalis suspension technique in congenital ptosis and in blepharophimosis-ptosis syndrome. Plast Reconstr Surg 1993, 92:1057-1060.
110. Zweep HP, Spauwen PH: Evaluation of expanded polytetrafluoroethylene (e-PTFE) and autogenous fascia lata in frontalis suspension: a comparative clinical study. Acta Chir Plast 1992, 34:129-137.
111. Moser G, Oberascher G: Reanimation of the paralyzed face with new gold weight implants and Goretex soft-tissue patches. Eur Arch Otorhinolaryngol Suppl 1997, 1:S76-78. The combined use of gold-weight implantation in the upper eyelid and polytetrafluoroethylene patches for resuspending the lower eyelid and midface appears to represent a successful approach to rehabilitating the patient with a facial palsy.
112. Sansone V, Boynton J, Palenski C: Use of gold weights to correct lagophthalmos in neuromuscular disease. Neurology, 1997, 48:1500-1503.
113. Gladstone GJ, Nesi FA: Management of paralytic lagophthalmos with a modified gold-weight implantation technique. Ophthal Plast Reconstr Surg 1996, 12:38-44.
114. Linder TE, Pike VE, Linstrom CJ: Early eyelid rehabilitation in facial nerve paralysis. Laryngoscope 1996, 106:1115-1118.
115. Dinces EA, Mauriello JA Jr, Kwartler JA, Franklin M: Complications of gold weight eyelid implants for treatment of fifth and seventh nerve paralysis. Laryngoscope 1997, 107:1617-1622 This is a good examination of the various complications associated with the use of gold-weight implants and the management of these complications.
116. Bair RL, Harris GJ, Lyon DB, Komorowski RA: Noninfectious inflammatory response to gold weight eyelid implants. Ophthal Plast Reconstr Surg 1995, 11:209-214.
117. Biel MA: GORE-TEX graft midfacial suspension and upper eyelid gold-weight implantation in rehabilitation of the paralyzed face. Laryngoscope 1995, 105:876-879.
118. Carlwright MJ, Frueh BR: Evaluation and clinical significance of the mechanical properties of various palpebral springs. Ophthal Plast Reconstr Surg 1995, 11:1-15.
119. Donnenfeld ED, Perry HD, Nelson DB: Cyanoacrylate temporary tarsorrhaphy in the management of corneal epithelial defects. Ophthalmic Surg 1991, 22:591-593
120. Khan JA: Cyanoacrylate-assisted trial eyelid repositioning for epiphora. Ophthal Plast Reconstr Surg 1991, 7:138-140.
121. Veloudios A, Kratky V, Heathcote JG, Lee M, Hurwitz JJ, Kazdan MS: Cyanoacrylate tissue adhesive in blepharoplasty. Ophthal Plast Reconstr Surg 1996, 12:89-97.
122. Nunery WR, Heinz GW, Bonnin JM, Martin RT, Cepela MA: Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg 1993, 9:96-104.